Equine Veterinary Therapeutics Market Outlook (2023 to 2033)

The global equine veterinary therapeutics market is expected to expand significantly and generate revenue of US$ 2,671.9 million by 2033 from US$ 1,378.7 million in 2023. This increase in revenue is made with an impressive CAGR value of 6.8%.

Historically the equine veterinary therapeutics market is generated US$ 1,307.6 million in 2022. There is expanding popularity of horse activities like racing and jumping which makes demand for equine veterinary therapeutics for care and treatment for horses if any horse gets any injury in these activities.
Equine veterinary therapy is a broad word that covers a wide range of horse therapies. These medicines have the potential to prevent, diagnose, and cure a wide range of diseases and medical conditions.

Horse owners are investing a large amount of money in the health of their animals as they are becoming more aware of the importance of care and treatment of their horses which brings the growth of the equine veterinary therapeutics market.

Regulations governing the use of horse veterinary medications have been established by governments. These rules are intended to ensure both the security and the effectiveness of these health care products. This is predicted to support the expansion of the equine veterinary treatments market, as owners of animals will be more willing to utilize medications that have received approval from the government.

Report Attribute Details
Equine Veterinary Therapeutics Market Value (2023) US$ 1,378.7 million
Equine Veterinary Therapeutics Market Anticipated Forecast Value (2033) US$ 2,671.9 million
Equine Veterinary Therapeutics Market Projected Growth Rate (2023 to 2033) 6.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Insights of Global Equine Veterinary Therapeutics Market (2017 to 2022)

The global equine veterinary therapeutics market expanded significantly from a revenue of US$ 1,052.2 million in 2017 to US$ 1,307.6 million in 2022 with an impressive CAGR of 4.4% during the historical period 2017 to 2022.

The global equestrian sports business is quickly expanding, which is fueling demand for equine veterinarian services. Horses are utilized in many sports, such as racing, show jumping, and dressage. These activities necessitate horses in peak physical condition, which increases the demand for preventative and therapeutic veterinary services.

Innovative Growth Strategies by Key Players to Thrive in the Competition

  • Educate the public about equine health.
  • Make use of digital platforms to reach a wider audience and provide better customer service.
  • Develop new vaccines that are effective against emerging diseases.
  • Focusing on customer satisfaction by offering demanded products, high-quality products and services.
  • Expand in new markets to get new customers from new markets.

Investment Opportunities in the Industry

  • Investing in research and development can stay ahead of the competition and meet the needs of horse owners and veterinarians.
  • Investing in partnerships with other organizations helps to develop new products and services, and to reach a wider audience.
  • Invest in sales and marketing, which will help to get more customers.

Regional Insights

The Rise of Equine Veterinary Therapeutics in North America

North America is the largest horse veterinary treatments market, accounting for 30.7% value share in global market. It is likely to expand more in the next decade. The veterinary treatments market in North America is expanding due to increased demand for anti-infectives, vaccinations, pain medications, digestive aids, and the strong research and development industry in North America, are driving the market.

Country The United States
2022 value share in Global Market 24.7%

The Future of Equine Veterinary Therapeutics in Europe

The European market for horse veterinary medications is extremely fragmented and has a value share of 35.2% in 2022, with many small and medium-sized businesses. However, a few huge international corporations play a significant influence in the industry. Many Europe companies manufacture horse goods including immunizations, antibiotics, anti-inflammatory medicines, and pain medications.

Country United Kingdom
Value CAGR (2023 to 2033) 4.8%
Country Germany
2022 value share in Global Market 6.2%

Asia Pacific is Riding the Wave of Growth in the Equine Veterinary Therapeutics Market

The adoption of technology is also playing a significant role in the growth of the Asia Pacific equine veterinary therapeutics market. New technologies are being developed that have the potential to transform the treatment of horse illnesses, like gene therapy, immunotherapy, and customized medicine. These technologies are projected to play a significant role in market growth in the future years in the region.

Country Japan
2022 value share in Global Market 4.4%
Country Value CAGR (2023 to 2033)
China 8.3%
India 6.8%
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Segment-wise Insights

Segment Name Segment Share
Topical 43.2
Veterinary Clinics 40.5

With the increased demand for anti-infectives, pain relievers, and digestive aid products, the topical section of the veterinary treatments market is expanding and has a segment share of 43.2%. The rising frequency of infectious illnesses, rising prevalence of chronic diseases, and rising pet obesity rates are all boosting demand for these items.

With rising demand for surgery, diagnostic testing, and preventive care, the veterinary clinics sector of the veterinary treatments market is expanding and has a segment share of 40.5%. The rising prevalence of animal injuries and diseases, the increased availability of diagnostic testing, and the expanding understanding of the value of preventative treatment are all boosting demand for these services.

Recent Developments

  • January 2023: Apoquel Tablets have been launched by Zoetis Inc. for the relief of atopic dermatitis in dogs and cats. Apoquel is a topical drug that acts by inhibiting the function of interleukin-13, a type of protein that is implicated in the growth of allergic skin irritation.
  • February 2023: Clavamox Soluble Oral Suspension has been launched by Boehringer Ingelheim Animal Health for the prevention and management of respiratory diseases in horses. Clavamox Soluble is a combined antibiotic that works against a variety of bacteria that cause respiratory infections in horses.
  • April 2023: Convenia Injectable Suspension has been launched by Elanco Animal Health for the relief of respiratory diseases in horses. Convenia is a powerful antibiotic that works against a variety of bacteria which may lead to respiratory infections in horses.
  • September 2022: Merck Animal Health has introduced Credelio Spot-On for flea and tick treatment in dogs. Credelio is a monthly spot-on therapy which is simple to use and works well against these types of parasites.
  • December 2022: Merck Animal Health has introduced Bravecto Topical Gel to fight fleas and ticks in cats. Bravecto is a monthly topical gel which is simple to use and offers good parasite prevention.

The Key Players in the Equine Veterinary Therapeutics Market

  • Merck Animal Heath
  • Affymetrix
  • Elanco Animal Health
  • Zoetis (Pfizer Animal Health)
  • Equine Health UK

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Profiled in the Equine Veterinary Therapeutics Market Survey

By Drugs:

  • Anti- Inflammatory
  • Anti - Infective
  • Parasiticides
  • Others

By Vaccines:

  • Recombinant vaccines
  • Inactivated Vaccines
  • Live attenuated vaccines
  • Others

By Feed Additives:

  • Vitamins
  • Antibiotics
  • Amino acids
  • Enzymes
  • Others

By Route of Administration:

  • Oral
  • Parental
  • Topical

By Distribution Channel:

  • Veterinary Hospital
  • Veterinary Clinics
  • Pharmacies and drug stores
  • E-commerce
  • Other

By Region:

  • North America
  • Latin America
  • The Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the growth rate of the equine veterinary therapeutics market from 2023 to 2033?

The equine veterinary therapeutics market is expected to expand at a CAGR of 6.8% from 2023 to 2033.

Which region is leading the global equine veterinary therapeutics market?

North America is the leading region in the global equine veterinary therapeutics market.

What is the market size of the global equine veterinary therapeutics market in 2023?

The global equine veterinary therapeutics market was valued at US$ 1,378.7 million in 2023.

What does the anticipated revenue of the equine veterinary therapeutics market until 2033?

The anticipated revenue of the equine veterinary therapeutics market until 2033 is US$ 2,671.9 million.

Which are some prominent equine veterinary therapeutics market manufacturers?

Zoetis, Boehringer Ingelheim, Merck Animal Health, Virbac, Elanco Animal Health, and Ceva Animal Health are prominent market manufacturers.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drugs

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Drugs, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drugs, 2023 to 2033

        5.3.1. Anti- Inflammatory

        5.3.2. Anti – Infective

        5.3.3. Parasiticides

        5.3.4. Others

    5.4. Y-o-Y Growth Trend Analysis By Drugs, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Drugs, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccines

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Vaccines, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Vaccines, 2023 to 2033

        6.3.1. Recombinant vaccines

        6.3.2. Inactivated Vaccines

        6.3.3. Live attenuated vaccines

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Vaccines, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Vaccines, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Feed Additives

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Feed Additives, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Feed Additives, 2023 to 2033

        7.3.1. Vitamins

        7.3.2. Antibiotics

        7.3.3. Amino acids

        7.3.4. Enzymes

        7.3.5. Others

    7.4. Y-o-Y Growth Trend Analysis By Feed Additives, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Feed Additives, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033

        8.3.1. Oral

        8.3.2. Parental

        8.3.3. Topical

    8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022

    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033

        9.3.1. Veterinary Hospital

        9.3.2. Veterinary Clinics

        9.3.3. Pharmacies and drug stores

        9.3.4. E-commerce

        9.3.5. Other

    9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022

    9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    10.1. Introduction

    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Western Europe

        10.3.4. Eastern Europe

        10.3.5. South Asia and Pacific

        10.3.6. East Asia

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. USA

            11.2.1.2. Canada

        11.2.2. By Drugs

        11.2.3. By Vaccines

        11.2.4. By Feed Additives

        11.2.5. By Route of Administration

        11.2.6. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drugs

        11.3.3. By Vaccines

        11.3.4. By Feed Additives

        11.3.5. By Route of Administration

        11.3.6. By Distribution Channel

    11.4. Key Takeaways

12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Brazil

            12.2.1.2. Mexico

            12.2.1.3. Rest of Latin America

        12.2.2. By Drugs

        12.2.3. By Vaccines

        12.2.4. By Feed Additives

        12.2.5. By Route of Administration

        12.2.6. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drugs

        12.3.3. By Vaccines

        12.3.4. By Feed Additives

        12.3.5. By Route of Administration

        12.3.6. By Distribution Channel

    12.4. Key Takeaways

13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Germany

            13.2.1.2. UK

            13.2.1.3. France

            13.2.1.4. Spain

            13.2.1.5. Italy

            13.2.1.6. Rest of Western Europe

        13.2.2. By Drugs

        13.2.3. By Vaccines

        13.2.4. By Feed Additives

        13.2.5. By Route of Administration

        13.2.6. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drugs

        13.3.3. By Vaccines

        13.3.4. By Feed Additives

        13.3.5. By Route of Administration

        13.3.6. By Distribution Channel

    13.4. Key Takeaways

14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Poland

            14.2.1.2. Russia

            14.2.1.3. Czech Republic

            14.2.1.4. Romania

            14.2.1.5. Rest of Eastern Europe

        14.2.2. By Drugs

        14.2.3. By Vaccines

        14.2.4. By Feed Additives

        14.2.5. By Route of Administration

        14.2.6. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drugs

        14.3.3. By Vaccines

        14.3.4. By Feed Additives

        14.3.5. By Route of Administration

        14.3.6. By Distribution Channel

    14.4. Key Takeaways

15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. India

            15.2.1.2. Bangladesh

            15.2.1.3. Australia

            15.2.1.4. New Zealand

            15.2.1.5. Rest of South Asia and Pacific

        15.2.2. By Drugs

        15.2.3. By Vaccines

        15.2.4. By Feed Additives

        15.2.5. By Route of Administration

        15.2.6. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Drugs

        15.3.3. By Vaccines

        15.3.4. By Feed Additives

        15.3.5. By Route of Administration

        15.3.6. By Distribution Channel

    15.4. Key Takeaways

16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. China

            16.2.1.2. Japan

            16.2.1.3. South Korea

        16.2.2. By Drugs

        16.2.3. By Vaccines

        16.2.4. By Feed Additives

        16.2.5. By Route of Administration

        16.2.6. By Distribution Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Drugs

        16.3.3. By Vaccines

        16.3.4. By Feed Additives

        16.3.5. By Route of Administration

        16.3.6. By Distribution Channel

    16.4. Key Takeaways

17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        17.2.1. By Country

            17.2.1.1. GCC Countries

            17.2.1.2. South Africa

            17.2.1.3. Israel

            17.2.1.4. Rest of MEA

        17.2.2. By Drugs

        17.2.3. By Vaccines

        17.2.4. By Feed Additives

        17.2.5. By Route of Administration

        17.2.6. By Distribution Channel

    17.3. Market Attractiveness Analysis

        17.3.1. By Country

        17.3.2. By Drugs

        17.3.3. By Vaccines

        17.3.4. By Feed Additives

        17.3.5. By Route of Administration

        17.3.6. By Distribution Channel

    17.4. Key Takeaways

18. Key Countries Market Analysis

    18.1. USA

        18.1.1. Pricing Analysis

        18.1.2. Market Share Analysis, 2022

            18.1.2.1. By Drugs

            18.1.2.2. By Vaccines

            18.1.2.3. By Feed Additives

            18.1.2.4. By Route of Administration

            18.1.2.5. By Distribution Channel

    18.2. Canada

        18.2.1. Pricing Analysis

        18.2.2. Market Share Analysis, 2022

            18.2.2.1. By Drugs

            18.2.2.2. By Vaccines

            18.2.2.3. By Feed Additives

            18.2.2.4. By Route of Administration

            18.2.2.5. By Distribution Channel

    18.3. Brazil

        18.3.1. Pricing Analysis

        18.3.2. Market Share Analysis, 2022

            18.3.2.1. By Drugs

            18.3.2.2. By Vaccines

            18.3.2.3. By Feed Additives

            18.3.2.4. By Route of Administration

            18.3.2.5. By Distribution Channel

    18.4. Mexico

        18.4.1. Pricing Analysis

        18.4.2. Market Share Analysis, 2022

            18.4.2.1. By Drugs

            18.4.2.2. By Vaccines

            18.4.2.3. By Feed Additives

            18.4.2.4. By Route of Administration

            18.4.2.5. By Distribution Channel

    18.5. Germany

        18.5.1. Pricing Analysis

        18.5.2. Market Share Analysis, 2022

            18.5.2.1. By Drugs

            18.5.2.2. By Vaccines

            18.5.2.3. By Feed Additives

            18.5.2.4. By Route of Administration

            18.5.2.5. By Distribution Channel

    18.6. UK

        18.6.1. Pricing Analysis

        18.6.2. Market Share Analysis, 2022

            18.6.2.1. By Drugs

            18.6.2.2. By Vaccines

            18.6.2.3. By Feed Additives

            18.6.2.4. By Route of Administration

            18.6.2.5. By Distribution Channel

    18.7. France

        18.7.1. Pricing Analysis

        18.7.2. Market Share Analysis, 2022

            18.7.2.1. By Drugs

            18.7.2.2. By Vaccines

            18.7.2.3. By Feed Additives

            18.7.2.4. By Route of Administration

            18.7.2.5. By Distribution Channel

    18.8. Spain

        18.8.1. Pricing Analysis

        18.8.2. Market Share Analysis, 2022

            18.8.2.1. By Drugs

            18.8.2.2. By Vaccines

            18.8.2.3. By Feed Additives

            18.8.2.4. By Route of Administration

            18.8.2.5. By Distribution Channel

    18.9. Italy

        18.9.1. Pricing Analysis

        18.9.2. Market Share Analysis, 2022

            18.9.2.1. By Drugs

            18.9.2.2. By Vaccines

            18.9.2.3. By Feed Additives

            18.9.2.4. By Route of Administration

            18.9.2.5. By Distribution Channel

    18.10. Poland

        18.10.1. Pricing Analysis

        18.10.2. Market Share Analysis, 2022

            18.10.2.1. By Drugs

            18.10.2.2. By Vaccines

            18.10.2.3. By Feed Additives

            18.10.2.4. By Route of Administration

            18.10.2.5. By Distribution Channel

    18.11. Russia

        18.11.1. Pricing Analysis

        18.11.2. Market Share Analysis, 2022

            18.11.2.1. By Drugs

            18.11.2.2. By Vaccines

            18.11.2.3. By Feed Additives

            18.11.2.4. By Route of Administration

            18.11.2.5. By Distribution Channel

    18.12. Czech Republic

        18.12.1. Pricing Analysis

        18.12.2. Market Share Analysis, 2022

            18.12.2.1. By Drugs

            18.12.2.2. By Vaccines

            18.12.2.3. By Feed Additives

            18.12.2.4. By Route of Administration

            18.12.2.5. By Distribution Channel

    18.13. Romania

        18.13.1. Pricing Analysis

        18.13.2. Market Share Analysis, 2022

            18.13.2.1. By Drugs

            18.13.2.2. By Vaccines

            18.13.2.3. By Feed Additives

            18.13.2.4. By Route of Administration

            18.13.2.5. By Distribution Channel

    18.14. India

        18.14.1. Pricing Analysis

        18.14.2. Market Share Analysis, 2022

            18.14.2.1. By Drugs

            18.14.2.2. By Vaccines

            18.14.2.3. By Feed Additives

            18.14.2.4. By Route of Administration

            18.14.2.5. By Distribution Channel

    18.15. Bangladesh

        18.15.1. Pricing Analysis

        18.15.2. Market Share Analysis, 2022

            18.15.2.1. By Drugs

            18.15.2.2. By Vaccines

            18.15.2.3. By Feed Additives

            18.15.2.4. By Route of Administration

            18.15.2.5. By Distribution Channel

    18.16. Australia

        18.16.1. Pricing Analysis

        18.16.2. Market Share Analysis, 2022

            18.16.2.1. By Drugs

            18.16.2.2. By Vaccines

            18.16.2.3. By Feed Additives

            18.16.2.4. By Route of Administration

            18.16.2.5. By Distribution Channel

    18.17. New Zealand

        18.17.1. Pricing Analysis

        18.17.2. Market Share Analysis, 2022

            18.17.2.1. By Drugs

            18.17.2.2. By Vaccines

            18.17.2.3. By Feed Additives

            18.17.2.4. By Route of Administration

            18.17.2.5. By Distribution Channel

    18.18. China

        18.18.1. Pricing Analysis

        18.18.2. Market Share Analysis, 2022

            18.18.2.1. By Drugs

            18.18.2.2. By Vaccines

            18.18.2.3. By Feed Additives

            18.18.2.4. By Route of Administration

            18.18.2.5. By Distribution Channel

    18.19. Japan

        18.19.1. Pricing Analysis

        18.19.2. Market Share Analysis, 2022

            18.19.2.1. By Drugs

            18.19.2.2. By Vaccines

            18.19.2.3. By Feed Additives

            18.19.2.4. By Route of Administration

            18.19.2.5. By Distribution Channel

    18.20. South Korea

        18.20.1. Pricing Analysis

        18.20.2. Market Share Analysis, 2022

            18.20.2.1. By Drugs

            18.20.2.2. By Vaccines

            18.20.2.3. By Feed Additives

            18.20.2.4. By Route of Administration

            18.20.2.5. By Distribution Channel

    18.21. GCC Countries

        18.21.1. Pricing Analysis

        18.21.2. Market Share Analysis, 2022

            18.21.2.1. By Drugs

            18.21.2.2. By Vaccines

            18.21.2.3. By Feed Additives

            18.21.2.4. By Route of Administration

            18.21.2.5. By Distribution Channel

    18.22. South Africa

        18.22.1. Pricing Analysis

        18.22.2. Market Share Analysis, 2022

            18.22.2.1. By Drugs

            18.22.2.2. By Vaccines

            18.22.2.3. By Feed Additives

            18.22.2.4. By Route of Administration

            18.22.2.5. By Distribution Channel

    18.23. Israel

        18.23.1. Pricing Analysis

        18.23.2. Market Share Analysis, 2022

            18.23.2.1. By Drugs

            18.23.2.2. By Vaccines

            18.23.2.3. By Feed Additives

            18.23.2.4. By Route of Administration

            18.23.2.5. By Distribution Channel

19. Market Structure Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Market Share Analysis of Top Players

        19.3.1. By Regional

        19.3.2. By Drugs

        19.3.3. By Vaccines

        19.3.4. By Feed Additives

        19.3.5. By Route of Administration

        19.3.6. By Distribution Channel

20. Competition Analysis

    20.1. Competition Deep Dive

        20.1.1. Merck Animal Heath

            20.1.1.1. Overview

            20.1.1.2. Product Portfolio

            20.1.1.3. Profitability by Market Segments

            20.1.1.4. Sales Footprint

            20.1.1.5. Strategy Overview

                20.1.1.5.1. Marketing Strategy

        20.1.2. Affymetrix

            20.1.2.1. Overview

            20.1.2.2. Product Portfolio

            20.1.2.3. Profitability by Market Segments

            20.1.2.4. Sales Footprint

            20.1.2.5. Strategy Overview

                20.1.2.5.1. Marketing Strategy

        20.1.3. Elanco Animal Health

            20.1.3.1. Overview

            20.1.3.2. Product Portfolio

            20.1.3.3. Profitability by Market Segments

            20.1.3.4. Sales Footprint

            20.1.3.5. Strategy Overview

                20.1.3.5.1. Marketing Strategy

        20.1.4. Zoetis (Pfizer Animal Health)

            20.1.4.1. Overview

            20.1.4.2. Product Portfolio

            20.1.4.3. Profitability by Market Segments

            20.1.4.4. Sales Footprint

            20.1.4.5. Strategy Overview

                20.1.4.5.1. Marketing Strategy

        20.1.5. Equine Health UK

            20.1.5.1. Overview

            20.1.5.2. Product Portfolio

            20.1.5.3. Profitability by Market Segments

            20.1.5.4. Sales Footprint

            20.1.5.5. Strategy Overview

                20.1.5.5.1. Marketing Strategy

        20.1.6. Olympia Equine Veterinary Services PLLC

            20.1.6.1. Overview

            20.1.6.2. Product Portfolio

            20.1.6.3. Profitability by Market Segments

            20.1.6.4. Sales Footprint

            20.1.6.5. Strategy Overview

                20.1.6.5.1. Marketing Strategy

        20.1.7. Ceva Sante Animale

            20.1.7.1. Overview

            20.1.7.2. Product Portfolio

            20.1.7.3. Profitability by Market Segments

            20.1.7.4. Sales Footprint

            20.1.7.5. Strategy Overview

                20.1.7.5.1. Marketing Strategy

        20.1.8. Eli Lilly and Company

            20.1.8.1. Overview

            20.1.8.2. Product Portfolio

            20.1.8.3. Profitability by Market Segments

            20.1.8.4. Sales Footprint

            20.1.8.5. Strategy Overview

                20.1.8.5.1. Marketing Strategy

        20.1.9. Virbac

            20.1.9.1. Overview

            20.1.9.2. Product Portfolio

            20.1.9.3. Profitability by Market Segments

            20.1.9.4. Sales Footprint

            20.1.9.5. Strategy Overview

                20.1.9.5.1. Marketing Strategy

        20.1.10. Bayer AG

            20.1.10.1. Overview

            20.1.10.2. Product Portfolio

            20.1.10.3. Profitability by Market Segments

            20.1.10.4. Sales Footprint

            20.1.10.5. Strategy Overview

                20.1.10.5.1. Marketing Strategy

21. Assumptions & Acronyms Used

22. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Equine Veterinary Therapeutics Market